These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 4765753)
1. Radiopaque contrast media. 28. Toxicologic studies with iodoxamic acid, a new intravenous cholegraphic agent. Tirone P; Rosati G Farmaco Sci; 1973 Dec; 28(12):1011-23. PubMed ID: 4765753 [No Abstract] [Full Text] [Related]
2. Radiopaque contrast media. XXVII. Pharmacologic properties of iodoxamic acid, a new contrast medium for intravenous cholegraphy. Rosati G; Schiantarelli P; Tirone P Farmaco Sci; 1973 Dec; 28(12):996-1010. PubMed ID: 4765762 [No Abstract] [Full Text] [Related]
3. [Hemodynamic effects in man of an injection of a new contrast medium for cholangiography]. Ambrosioni E; Catizone L; Chiarini C; Costa V; Perri G G Clin Med; 1972 Mar; 53(3):132-41. PubMed ID: 4567883 [No Abstract] [Full Text] [Related]
4. Intravenous cholegraphy and peroral contraceptives. A preliminary report. Lindgren P; Saltzman GF; Zeuchner E Acta Radiol Diagn (Stockh); 1974 Mar; 15(2):217-24. PubMed ID: 4827361 [No Abstract] [Full Text] [Related]
5. Cholangiographic excretion studies: a comparison of iodipamide and iodoxamate in the dog. Evill CA; Benness GT Invest Radiol; 1976 SEP-OCT; 11(5):459-63. PubMed ID: 989759 [TBL] [Abstract][Full Text] [Related]
6. Local toxicity of metrizamide on intravascular injection. Effect on kidney, liver and blood-brain barrier. Salvesen S Acta Radiol Suppl; 1973; 335():166-74. PubMed ID: 4534550 [No Abstract] [Full Text] [Related]
7. Increased nephrotoxicity caused by combined cholecystography? (Animal experiment). Bor K; Elek S; Elekes I; Polgari I; Csakany G Rays; 1985; 10(3):61-5. PubMed ID: 3843670 [No Abstract] [Full Text] [Related]
8. [Pharmacology of iotroxic acid, a new intravenous cholangiographic agent. II. Experimental animal study of side effects]. Speck U; Düsterberg B; Mannesmann G; Siefert HM Arzneimittelforschung; 1978; 28(12):2290-6. PubMed ID: 582945 [TBL] [Abstract][Full Text] [Related]
10. [Effects of new angiographic contrast media on the cardio-respiratory- and central nervous system]. sebök ZB; Szlávy L Arzneimittelforschung; 1967 Nov; 17(11):1380-6. PubMed ID: 5632272 [No Abstract] [Full Text] [Related]
11. Radiopaque contrast media. XXV. Physicochemical properties of iodoxamic acid, a new intravenous cholecystographic agent. Felder E; Pitré D; Grandi M Farmaco Sci; 1973 Nov; 28(11):925-36. PubMed ID: 4762845 [No Abstract] [Full Text] [Related]
12. [Pharmacological study of reumycin]. Veĭs RA; Storozhsev IA Antibiotiki; 1968 Nov; 13(11):1014-21. PubMed ID: 5712468 [No Abstract] [Full Text] [Related]
16. Clinical trial of ioglycamate, a new intravenous cholangiographic medium. Masterson JB J Ir Med Assoc; 1973 Aug; 66(16):442-4. PubMed ID: 4732631 [No Abstract] [Full Text] [Related]
17. [Toxicity problems with respect to angiographic contrast media]. Zsebök ZB; Szlávy L Int Z Klin Pharmakol Ther Toxikol; 1970 May; 3(2):157-62. PubMed ID: 5425957 [No Abstract] [Full Text] [Related]
18. Biologic tolerance of the central nervous system to metrizamide. Gonsette RE Acta Radiol Suppl; 1973; 335():25-44. PubMed ID: 4534561 [No Abstract] [Full Text] [Related]
20. [Effect of intravenous injections of contrast media on the kidney. Experiments in dogs. II]. Lélek I Fortschr Geb Rontgenstr Nuklearmed; 1971 Mar; 114(3):367-72. PubMed ID: 5103283 [No Abstract] [Full Text] [Related] [Next] [New Search]